Journal article
Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation
Abstract
BACKGROUND: RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) is an international multicenter study (18,113 patients from 967 centers in 44 countries) that demonstrated the ability of dabigatran to reduce the occurrence of both stroke and hemorrhage in patients who had atrial fibrillation (AF) with high risks of stroke compared with patients who received warfarin. From Japan, 326 patients were randomized in RE-LY.
METHODS AND …
Authors
Hori M; Connolly SJ; Ezekowitz MD; Reilly PA; Yusuf S; Wallentin L; the RE-LY Investigators
Journal
Circulation Journal, Vol. 75, No. 4,
Publisher
Japanese Circulation Society
Publication Date
2011
DOI
10.1253/circj.cj-11-0191
ISSN
1346-9843